All lobbying filings

THE PROCTER AND GAMBLE COMPANY

Lobbying for THE PROCTER AND GAMBLE COMPANY

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $751,000.00 expenses · posted Oct 22, 2025

Official filing document

Bills named in this filing 3

HR 4273
Over-the-Counter Monograph Drug User Fee Amendments
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
S 2003
Strengthening Benefit Plans Act of 2025

Lobbying activity 9

Pharmacy

-Issues related to FDA review of active ingredients in over-the-counter products

Health Issues

-H.R.4273: Over-the-Counter Monograph Drug User Fee Amendments (Entire Bill)

Chemicals/Chemical Industry

-Issues related to Toxic Substances Control Act reform (No Bill)

Environment/Superfund

-Issues related to plastics recycling (No Bill)

Taxation/Internal Revenue Code

-OECD Digital Tax Project (Global Minimum Tax Implementation) -Implementation of H.R. 1 (One Big Beautiful Bill - Corporate/International Tax Provisions) -S.2003 (Strengthening Benefit Plans Act of 2025) -H.R. 1 (One Big Beautiful Bill Act - Corporate/International Tax Provisions)

Trade (domestic/foreign)

-Issues related to IEEPA Reciprocal Tariffs -Issues related to Softwood Lumber 232 Trade Investigation -Issues related to America First Trade Policy -Issues related to tariffs (232 Pharmaceuticals)

Trucking/Shipping

-Issues Related to Gross Vehicle Weight Limits (no bill)

Foreign Relations

-Issues related to Asia-Pacific Economic Cooperation (APEC) -Issues related to Middle East (Syria US export controls) -Issues related to Latin America

Consumer Issues/Safety/Products

-Issues related to product safety

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.